A preliminary randomized controlled trial of a distress tolerance treatment for opioid dependent persons initiating buprenorphine

Background Buprenorphine opioid agonist treatment (OAT) has established efficacy for treating opioid dependency but early relapse rates are high and are often associated with withdrawal-related or emotional distress.